Scarica l'app Stockscreener
56.56
7.94%
4.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Why Hims & Hers Health, Inc. (HIMS) Surged On Friday - Insider Monkey
Hims to cut 4% of workforce amid ban on weight-loss drug copies - Reuters
Telehealth Firm Hims Cuts 4% of Staff in Strategy Shift - Bloomberg.com
Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer - MSN
Hims & Hers Health trims workforce amid strategic realignment - Investing.com Australia
Hims & Hers Health trims workforce amid strategic realignment By Investing.com - Investing.com Canada
Hims & Hers Health Inc (HIMS) Shares Up 3.02% on May 30 - GuruFocus
Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy? - TradingView
Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health Stock: After Doubling, It May Be Too Late To Buy (NYSE:HIMS) - Seeking Alpha
HIMS: AI Advancements Set to Boost Direct-to-Consumer Value | HIMS Stock News - GuruFocus
Is HIMS stock about to get 'Squid Game' treatment? - Investorsobserver
Why Hims & Hers Health Inc. (HIMS) Went Down On Tuesday - Insider Monkey
10 Stocks Got Wiped Out. Are You Holding Any? - Insider Monkey
SA analyst downgrades: NVDA, OKTA, HIMS, DDOG, WDAY, RNG - Seeking Alpha
3 Surprising Stocks That Have More Than Doubled in 2025 - AOL.com
3 Surprising Stocks That Have More Than Doubled in 2025 - The Motley Fool
Hims & Hers Health (HIMS) – Research Analysts’ Weekly Ratings Updates - Defense World
Medical Stocks To Watch Now – May 24th - Defense World
Hims & Hers Health (NYSE:HIMS) Trading Up 2.8% – Here’s What Happened - Defense World
Super Micro Computer, Hims & Hers And Aurora Innovation Are Among Top 10 Large-Cap Losers Last Week (May 19-May 23): Are The Others In Your Portfolio? - Benzinga
Hims & Hers Health: New Guidance Creates Huge Risk For Shorts (NYSE:HIMS) - Seeking Alpha
Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle - Yahoo Finance
‘Time to Choose Sides on HIMS Stock’ as Analysts Assign Mixed Ratings - The Globe and Mail
Mixed options sentiment in Hims and Hers Health with shares up 2.0% - TipRanks
HIMS Stock Sees Moderate Options Activity with Increased Downside Demand | HIMS Stock News - GuruFocus
Hims & Hers: Not The Dip I Want To Buy (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers appoints Farshad Shadloo as VP of communications - Medical Marketing and Media
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Validea Detailed Fundamental AnalysisHIMS - Nasdaq
When the Price of (HIMS) Talks, People Listen - news.stocktradersdaily.com
Hims Online Psychiatry 2025 Review - Everyday Health
Why Hims & Hers Health (HIMS) Stock Is Falling Today - Yahoo
Hims & Hers Introduces 6-Month Wegovy New Customer Offer - marketscreener.com
HIMS Launches Affordable Wegovy Access for Eligible Customers | - GuruFocus
Hims & Hers offers Wegovy at new accessible price By Investing.com - Investing.com India
HIMS Launches Affordable Wegovy Access for Eligible Customers | HIMS Stock News - GuruFocus
U.S. Markets Finished Mixed Thursday As Snowflake Led, Hims & Hers Health Lagged - Barron's
Hims & Hers offers Wegovy at new accessible price - Investing.com
Citi maintains Sell on Hims & Hers, holds $30 price target - Investing.com
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer - galvnews.com
Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off? - MarketBeat
Hims & Hers Health Inc (HIMS) Stock Price Down 4.07% on May 22 - GuruFocus
Cigna’s $200 Weight-Loss Drug Cap Shakes Up Hims & Hers Stock - Wall Street Pit
Citi maintains sell rating on Hims & Hers with $30 target - Investing.com India
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull - MSN
Snowflake stock gains, Nvidia & Navitas, Hims & Hers slips - Yahoo Finance
HIMS Stock Declines by Over 10% Marking Significant Drop | HIMS - GuruFocus
Hims & Hers Health Stock Is Tumbling Thursday: What's Happening?Hims & Hers Health (NYSE:HIMS) - Benzinga
HIMS Stock Declines by Over 10% Marking Significant Drop | HIMS Stock News - GuruFocus
HIMS Stock Experiences Notable Decline | HIMS Stock News - GuruFocus
HIMS Shares Decline Following Evernorth Weight Loss Plan Announcement | HIMS Stock News - GuruFocus
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit - Reuters
Up 157% in 2025, Is It Too Late to Buy Hims & Hers Stock? - AOL.com
Truist maintains Hims & Hers stock hold rating, $45 target By Investing.com - Investing.com Nigeria
Morgan Stanley maintains Hims & Hers stock with $40 target By Investing.com - Investing.com Nigeria
Morgan Stanley maintains Hims & Hers stock with $40 target - Investing.com
Hims & Hers Health: Stabilizing Growth and Cautious Revenue Guidance Lead to Hold Rating - TipRanks
2.52%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):